Autobio Diagnostics financials at a glance

+ Portfolio

The revenue of Autobio Diagnostics is reported as 4.44366 billion Yuan Renminbi in the fiscal year 2023. The earnings were 2.04 Yuan Renminbi per share in 2023, which was 6.25 higher than 2022. And about 0.56944 billion Yuan Renminbi are reported as free cash flow in the financials of Autobio Diagnostics 2023. Dividends of 1.05 Yuan Renminbi per share were paid to shareholders of Autobio Diagnostics stock SHSE:603658 in fiscal 2023.

¥4.44B

Revenue

¥2.04

Earnings Per Share

63.73%

Gross Margin %

¥0.00M

Free Cash Flow

Revenue

4,443.66

Earnings Per Share

2.04

Gross Margin %

63.73

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2015
Rev.	Revenue	N/A	¥4.44B	¥4.44B	¥3.77B	¥2.98B	¥0.00M
GM %	Gross Margin %	61.92%	63.73%	58.47%	58.99%	59.17%	0.00%
OM	Operating Margin	25.55%	27.15%	25.37%	25.33%	26.21%	0.00%
EPS	Earnings Per Share	¥2.01	¥2.04	¥1.92	¥1.63	¥1.22	¥0.54
Div.	Dividends	N/A	¥1.05	¥0.80	¥0.72	¥0.65	¥0.00
PR %	Payout Ratio %	0	51.47%	41.67%	44.17%	53.28%	0
Sha.	Shares	N/AM	581.01M	581.01M	586.27M	586.27M	491.4M
OCF	Operating Cash Flow	N/A	¥1.47B	¥1.56B	¥1.46B	¥994.71M	¥0.00M
FCF	Free Cash Flow	N/A	¥569.44M	¥620.10M	¥395.39M	¥-,120.67M	¥0.00M
FCFS	Free Cash Flow Per Share	¥1.05	¥0.98	¥1.06	¥0.67	¥-0.22	¥0.00

Autobio Diagnostics financials at a glance

Financials

Discover